Mirabegron

Br J Clin Pharmacol. 2015 Oct;80(4):762-4. doi: 10.1111/bcp.12647. Epub 2015 Jun 5.

Abstract

Mirabegron is used for the treatment of symptoms associated with overactive bladder syndrome. It selectively stimulates the β3 -adrenoreceptor, which relaxes the detrusor muscle. This improves urine storage by distension of the bladder body.

MeSH terms

  • Acetanilides / adverse effects
  • Acetanilides / pharmacology*
  • Acetanilides / therapeutic use*
  • Adrenergic beta-3 Receptor Agonists / pharmacology*
  • Humans
  • Neuromuscular Agents / pharmacology*
  • Thiazoles / adverse effects
  • Thiazoles / pharmacology*
  • Thiazoles / therapeutic use*
  • Urinary Bladder / drug effects*
  • Urinary Bladder, Overactive / drug therapy*

Substances

  • Acetanilides
  • Adrenergic beta-3 Receptor Agonists
  • Neuromuscular Agents
  • Thiazoles
  • mirabegron